- Home
- ATNM vs USEG Comparison
ATNM vs USEG Comparison
Compare ATNM & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- USEG
- Stock Information
- Founded
- ATNM 2000
- USEG 1966
- Country
- ATNM United States
- USEG United States
- Employees
- ATNM N/A
- USEG N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- USEG Oil & Gas Production
- Sector
- ATNM Health Care
- USEG Energy
- Exchange
- ATNM Nasdaq
- USEG Nasdaq
- Market Cap
- ATNM 49.0M
- USEG 42.2M
- IPO Year
- ATNM N/A
- USEG N/A
- Fundamental
- Price
- ATNM $1.72
- USEG $1.21
- Analyst Decision
- ATNM Strong Buy
- USEG Strong Buy
- Analyst Count
- ATNM 2
- USEG 1
- Target Price
- ATNM $4.50
- USEG $3.50
- AVG Volume (30 Days)
- ATNM 176.2K
- USEG 356.0K
- Earning Date
- ATNM 08-08-2025
- USEG 08-12-2025
- Dividend Yield
- ATNM N/A
- USEG N/A
- EPS Growth
- ATNM N/A
- USEG N/A
- EPS
- ATNM N/A
- USEG N/A
- Revenue
- ATNM N/A
- USEG $12,542,000.00
- Revenue This Year
- ATNM N/A
- USEG N/A
- Revenue Next Year
- ATNM N/A
- USEG $120.38
- P/E Ratio
- ATNM N/A
- USEG N/A
- Revenue Growth
- ATNM N/A
- USEG N/A
- 52 Week Low
- ATNM $1.03
- USEG $0.87
- 52 Week High
- ATNM $2.41
- USEG $6.40
- Technical
- Relative Strength Index (RSI)
- ATNM 54.44
- USEG 44.72
- Support Level
- ATNM $1.60
- USEG $1.17
- Resistance Level
- ATNM $1.79
- USEG $1.21
- Average True Range (ATR)
- ATNM 0.10
- USEG 0.04
- MACD
- ATNM 0.01
- USEG 0.01
- Stochastic Oscillator
- ATNM 76.25
- USEG 50.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.